Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA.
David Geffen School of Medicine at UCLA, Los Angeles, CA.
Ann Surg. 2018 Jul;268(1):48-57. doi: 10.1097/SLA.0000000000002712.
The aim of this study was to systematically review the risks and benefits of interventions designed to reduce intraoperative costs.
Episode-based payments shift financial risk from insurers onto hospitals and providers. The operating room (OR) is a resource dense environment and there is growing interest in identifying ways to reduce intraoperative costs while maintaining patient safety.
We searched PubMed, Cochrane, and CINAHL for articles published between 2001 and March 2017 that assessed interventions designed to reduce intraoperative costs. We grouped interventions into 6 categories: standardization of instruments, switching to reusable instruments or removing instruments from trays, wound closure comparisons, cost feedback to surgeons, head-to-head instrument trials, and timely arrival of surgeon to the OR.
Of 43 included studies, 12 were randomized trials and 31 were observational studies. Gross cost estimates ranged from -$413 (losses) to $3154 (savings) per operation, with only 2 studies reporting losses; however, studies had significant methodologic limitations related to cost data. Studies evaluating standardization and cost feedback were the most robust with estimated cost savings between $38 and $732/case, with no change in OR time, length of stay, or adverse events.
Almost all studies assessing interventions to reduce intraoperative costs have demonstrated cost savings with no apparent increase in adverse effects. Methodologic limitations, especially related to cost data, weaken the reliability of these estimates for most intervention categories. However, hospitals seeking to reduce costs may be able to do so safely by standardizing operative instruments or providing cost feedback to surgeons.
本研究旨在系统地回顾旨在降低术中成本的干预措施的风险和益处。
基于疾病的支付方式将财务风险从保险公司转移到医院和提供者身上。手术室(OR)是资源密集型环境,人们越来越有兴趣寻找在保持患者安全的同时降低术中成本的方法。
我们在 2001 年至 2017 年 3 月期间,在 PubMed、Cochrane 和 CINAHL 上搜索了评估旨在降低术中成本的干预措施的文章。我们将干预措施分为 6 类:仪器标准化、改用可重复使用的仪器或从托盘上移除仪器、伤口闭合比较、向外科医生提供成本反馈、仪器直接比较以及外科医生及时到达手术室。
在 43 项纳入的研究中,有 12 项是随机试验,31 项是观察性研究。总费用估计值从每例手术的 -$413(损失)到$3154(节省)不等,只有 2 项研究报告了损失;然而,这些研究在成本数据方面存在严重的方法学局限性。评估标准化和成本反馈的研究最可靠,估计每例节省 38 至 732 美元,手术时间、住院时间或不良事件没有变化。
几乎所有评估降低术中成本的干预措施的研究都表明,成本节省而无明显不良影响增加。由于成本数据方面的方法学局限性,削弱了这些估计值在大多数干预类别中的可靠性。但是,寻求降低成本的医院可能能够通过标准化手术器械或向外科医生提供成本反馈来安全地实现这一目标。